| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 中广核核技术发展股份有限公司(股票简称:中广核技,股票代码:000881.SZ)是中国广核集团(简称"中广核")"6+1"产业体系非动力核技术应用产业发展平台、中国非动力核技术应用产业龙头企业、中国非动力核技术应用第一股,努力发展成为中广核新的支柱产业,并向世界一流核技术应用产业领跑者迈进。 作为国务院国资委"双百行动"综合改革企业和国家发改委第四批"混合所有制"改革试点企业,公司持续探索混合所有制发展新模式,实现了国有资本与民营资本的融合发展。公司以"核技术让人类生活更美好"为使命,聚焦核技术应用产业,以A+战略为引领,围绕医疗健康、检测设备、加速器与辐照、高分子材料四大业务布局深化拓展。 | ||||||||||||||||||||||||
| Main Business | 医疗健康、电子加速器与辐照、新材料、测控装备等业务 | ||||||||||||||||||||||||
| Legal Representative | 盛国福 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 胡小林 | ||||||||||||||||||||||||
| Solicitors | 上海市锦天城律师事务所 | ||||||||||||||||||||||||
| Auditors | 信永中和会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
| Tel No | 0755-88619309;0755-88619879 | ||||||||||||||||||||||||
| Fax No | 0755-88619309;0755-84434946-619331 | ||||||||||||||||||||||||
| Website | www.cgnnt.com.cn | ||||||||||||||||||||||||
| business_ATC@cgnpc.com.cn;yangxinchun@cgnpc.com.cn;wuweiwei@cgnpc.com.cn | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 02/09/1998 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ -0.304 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 5.329 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 5.938B |
![]() |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |